Inato is a platform designed for clinical trials that can unlock research site potential.
Inato has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Inato's investors include Cathay Innovation, Obvious Ventures, Fly Ventures, Kima Ventures, Serena.
Inato is headquartered in Paris, France.
Inato is a platform designed for clinical trials that can unlock research site potential.
Inato is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inato — Funding & Investors." VCBacked, March 29, 2023, https://www.vcbacked.co/company/inato. Accessed July 20, 2026.
VCBacked. (2023). Inato — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/inato
{{cite web |title=Inato — Funding & Investors |url=https://www.vcbacked.co/company/inato |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated